14-Jan-16 Philips has announced an agreement with the Sijunjung Regency in West Sumatra, Indonesia, for full-scale commercial implementation - Philips’ first globally - of its Mobile Obstetrics Monitoring (MOM) service. The smartphone service identifies mothers-to-be at high risk and enables midwives in remote locations to share data and ultrasound images with obstetricians in the country’s larger hospitals, for improved decision-making. [image: Philips]

15-Dec-15 Ovitz Corporation, a startup that develops portable devices to check eyes, is set to support developing countries. Kim Joung-yoon, CEO of Ovitz, said “There are 4.5 billion people across the globe in need of visual correction, and 80% of cases are preventable... However, it is actually very difficult for the disadvantaged in developing countries to get proper eye exams." [image: Business Korea]

01-Dec-15 At a recent India-Africa summit, Prime Minister Modi discussed working together to improve public health with 54 African heads of state. For India, the main goal is to increase pharmaceutical exports to Africa, while African ministers are keen to copy India’s success in developing drug manufacturing, both to secure their own supplies and to give their economies a fillip. [image: Reuters]

03-Nov-15 In the first quarter after its merger, Zimmer Biomet has reported it expects to complete commercial integration by the end of 2015. It also reported progress on its sales channel integration, evidenced by sequential sales improvement in its Asia-Pacific and Europe, Middle East & Africa (EMEA) regions, where Knee orthopaedics sales increased 9% and 6% respectively. [image: Zimmer Biomet]

04-Nov-15 Investor The Abraaj Group has taken a majority stake in Al Kindy, Casablanca's largest private oncology clinic, and Menara, a leading oncology and imaging diagnostics center in Marrakech. Al Kindy and Menara together form the largest private integrated network of imaging diagnostics and cancer treatment centers in Morocco, expected collectively to treat more than 10,000 patients in 2015. [image: The Abraaj Group].